Answer
Mirapexin (pramipexole) tablets are licensed in adults for signs and symptoms of idiopathic Parkinson’s disease, alone or with levodopa through late stages, and symptomatic treatment of moderate to severe idiopathic restless legs syndrome at doses up to 0.54 mg base (0.75 mg salt).
Sources for this answer
- MIRAPEXIN 0.088 mg/0.18 mg/0.35 mg/0.7 mg tabletsBoehringer Ingelheim Limited · emc · SmPC §4.1 Therapeutic Indications · Version 36Document updated
Sources checked